Prof. H. Michel
Prof. R. Huber
Two Nobel Prize winners, R. Huber and H. Michel, were invited to attend a panel to select the director for a newly established CAS institute. The meeting, which was chaired by CAS Vice President Chen Zhu, was held on Oct. 24 in Guangzhou, capital of south China's Guangdong Province.
The institute, Guangzhou Institute of Biomedicine and Health Sciences (GIBHS), was jointly established by CAS, Guangdong Province and Guangzhou City under an agreement concluded in July, and an international search for its directors and senior researchers started soon afterwards. Nine candidates had been selected from over 30 applicants to be interviewed by the panel. Three finalists have been chosen by ballot, paving the way for the final decision of the appointment.
A major joint venture with local governments, GIBHS strives to improve the local capacities in original innovation and system integration in biomedicine and healthcare by focusing on applied basic research and high-tech development. In line with the local economic and social demands, it will conduct research into the cause, prevention and treatment of major diseases in the region, and develop new healthcare products.
